文献速递多重用药衰弱、肌少症与跌倒老年慢病共病管理

减药与降低死亡率和住院率的相关性:一项实用性阶梯楔形整群随机对照试验

Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
PubMed 文献 · J Am Med Dir Assoc · 2020-05-15

该研究在新加坡4家养老院纳入65岁及以上、服用5种及以上药物的居民,采用实用性多中心阶梯楔形整群随机对照设计,评估药师主导的5步团队照护减药干预。干预未减少跌倒,但与死亡率降低(HR 0.16,95%CI 0.07-0.41;

要点

  • 药师主导的多学科5步减药干预未减少跌倒,但显著降低死亡率和住院居民数。
  • 约四分之三由药师发起的减药干预被医生接受。

核心结论

  • 多学科药物审查导向的减药与养老院居民死亡率和住院居民数减少相关,应考虑用于所有养老院居民。

主要发现

  • 6个月时减药干预未减少跌倒。
  • 前后分析显示研究结束时药片负担减少,研究人群每日费用保守估计节省11.42美元(15.65新加坡元)。

关键数值与推荐

  • 减药干预为药师主导的5步团队照护药物审查,药师与医生、护士讨论减药可行性,并使用Beers和STOPP标准实施。
  • 约四分之三由药师发起的减药干预被医生接受。

临床怎么用

  • 在养老院居民中可考虑实施药师主导的多学科减药干预,以降低死亡率和住院居民数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Deprescribing has gained awareness recently, but the clinical benefits observed from randomized trials are limited. The aim of this study was to examine the effectiveness of a pharmacist-led 5-step team-care deprescribing intervention in nursing homes to reduce falls (fall risks and fall rates). Secondary aims include reducing mortality, number of hospitalized residents, pill burden, medication cost, and assessing the deprescribing acceptance rate. DESIGN: Pragmatic multicenter stepped-wedge cluster randomized controlled trial. SETTING AND PARTICIPANTS: Residents across 4 nursing homes in Singapore were included if they were aged 65 years and above, and taking 5 or more medications. METHODS: The intervention involved a 5-step deprescribing intervention, which involved a multidisciplinary team-care medication review with pharmacists, physicians, and nurses (in which pharmacists discussed with other team members the feasibility of deprescribing and implementation using the Beers and STOPP criteria) or to an active waitlist control for the first 3 months. RESULTS: Two hundred ninety-five residents from 4 nursing homes participated in the study from February 2017 to March 2018. At 6 months, the deprescribing intervention did not reduce falls. Subgroup analysis showed that intervention reduced fall risk scores within the deprescribing-naïve group by 0.18 (P = .04). Intervention was associated with a reduction in mortality [hazard ratio (HR) 0.16, 95% confidence interval 0.07, 0.41; P < .001] and number of hospitalized residents (HR 0.16, 95% CI 0.10, 0.26; P < .001). Pre-post analysis witnessed a reduction in pill burden at the end of the study, and a conservative daily cost saving estimate of US$11.42 (SG$15.65) for the study population. Approximately three-quarters of deprescribing interventions initiated by the pharmacists were accepted by the physicians. CONCLUSIONS AND IMPLICATIONS: Multidisciplinary medication review-directed deprescribing was associated with reductions in mortality and number of hospitalized residents in nursing homes and should be considered for all nursing home residents.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Kua CH, Yeo CYY, Tan PC, et al. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial. J Am Med Dir Assoc. 2020. PMID: 32423694. doi:10.1016/j.jamda.2020.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。